141322 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-31 |
| Register Year | 2014 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | Bevacizumab |
| Trade Name | AVASTIN 100 solution for infusion |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L01XC07 |
| Atc Code2 | |
| Size | 4 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $1235.55 |
| Shelf Life | 24 Months |
| Marketing Company | ROCHE & CO LTD |
| Marketing Country | Switzerland |
| Manufacture Name | ROCHE DIAGNOSTICS |
| Manufacture Country | Germany |
| Secondry package manufacture | |
| Main Agent | ALNAGHI COMPANY |
| Secosnd Agent | |
| Third Agent | |
| Visits | 141322 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| AVASTIN 100 solution for infusion | $1235.55 | 141322 visits | 2022-08-31 |
| AVASTIN 400 solution for infusion | $4271.4 | 170186 visits | 2022-08-31 |